UK researchers announced a breakthrough gene therapy that slowed Huntington’s disease for the first time. Early-stage trials at University College London showed some patients’ condition progressed 75% slower over three years. The therapy, AMT-130, is delivered via direct brain injection.
Trending
- Italy art police seize 21 suspected fake works from Salvador Dalí show | Salvador Dalí
- Swedish Lawmakers Push for Strategic Bitcoin Reserve
- Osimhen’s Goal Lifts Galatasaray To UCL Win Over Liverpool
- Morocco arrests hundreds of protesters as rallies turn violent | Protests News
- Jaxson Dart, Giants star, remembers how the New Orleans Saints passed on him and sends a strong warning
- GCAI hosts legal leaders to chart vision for reform roadmap
- Charities worried about possible drop in Thanksgiving donations due to Canada Post strike
- Situation ‘Critical’ As Zaporizhzhya Nuclear Plant Runs On Emergency Generators
